Anticancer drug names under consideration by the
Adopted Names (USAN)
Program: United States
afusertib, inolisib, nesvacumab, nindetanib
A name published in the USP Dictionary of USAN and International Nonproprietary Names, and on the United States Adopted Names Web site, shall be the effective equivalent of an intellectual property right on the part of the relevant entities.
afursertib: treatment of hematological cancers
inolisib: treatment of cancer
nesvacumab: treatment of cancer